Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tropisetron for myocardial protection in cardiac valve replacement surgery
ChiCTR1800018681Phase 4Recruiting
- Sponsor
- Xingrui Industry
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tropisetron in cardiac morbidity (2 arms), sponsored by Xingrui Industry. Primary endpoints: Cardiac troponin I, Creatine kinase MB and 1 more. Started Aug 2018; status: recruiting.
02
Drugs
tropisetron
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on ChiCTR1800018681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018681.